top of page

General meeting

09:30

17:30

10:30

14:30

15:00

18:00

20:30

P.4. Accesses

Presidency: E. Efthimiou, D. Kirmizis

1. AVF dysfunction: diagnosis and treatment  

  Evdokia Efthymiou

2. Tenckhoff catheter insertion - Medical

Praveen Ande

3. Tenckhoff catheter insertion - Surgical

Fahed Youssef

  P.5. Resolving cardio-renal-metabolic syndrome

Presidency: E. Fousteris, A. Papazafeiropoulou

Commentator: D. Vlachakos, D. Kirmizis

1. Review of the guidelines

Evangelos Fousteris

2. SGLT2 inhibitors: are they all the same?

E. Korakas

3. The central role of incretin hormones

Konstantinos Balabanis

4. Cardio-renal-metabolic syndrome from the perspective of the Nephrologist

Panagiotis Nennes

Sunday, September 15

Challenges and prospects in Nephrology

Challenges24-poster_edited.jpg

P.3. Hypertension

Presidency: D. Vlachakos, A. Zagorianakos

Commentators: E. Intzevidou, G. Hadjivasiliou

1. Hypertension in CKD: Evaluation and treatment

    Dimitrios Vlachakos

2. Hypertension on dialysis

    Antonios Zagorianakos

3. Posterior reversible encephalopathy syndrome

    Gregory Myserlis

ERATO Hall

SAPPHORE Hall

P.6. Latest in systemic diseases

Presidency: V. Kolovos, I. Droulias

Commentator: D. Moysiadis

1. Atypical hemolytic uremic syndrome and TMA

Eleni Gavrilaki

2. Monoclonal gammopathies

Vasilios Chatziantoniou

3. Polycystic kidney disease: new developments in diagnostic and therapeutic approach

Mahel Chintana Galahitiyawa

4. Lupus nephritis: what's new

Jeff Eberhard

General meeting

P.3. Quality of services and patient safety in Hemodialysis Units

1. The experience of the British Health System

and the Greek Units

2. Presentation of the Unit evaluation system

D.3. Endovascular fistula creation systems              Alexander Mallios   

Break

D.4. The use of continuous glucose monitoring systems in people with diabetes: Basic concepts

Athanasia Papazafeiropoulou

P.8. Latest in the treatment of CKD

Presidency: D. Bakoulis, E. Heliotis

1. Stroke prevention in CKD

Manolis Tzambarlis

2. Calcimitics: their place in clinical practice

Dimitrios Bakoulis

3. Prevention & treatment of osteoporosis

Eleni Helioti

P.7. Newer treatments in CKD

Presidency: A. Gombou, P. Kompotiatis

Commentator: I. Droulias

1. HIF-pH inhibitors

Athena Gombou

2. Treatment of hyperkalemia

Vaia Raikou

3. Latest in iron therapy

Panagiotis Kompotiatis

4. Newer oral anticoagulants

Konstantinos Psounis

D.6. What's new in the monitoring and treatment of IgA nephropathy

Vasilios Kolovos

D.5. Treatment and outcome of heart failure in CKD

George Tzanis

D.7. Latest developments in the treatment of uremic pruritus

Olga Hellina

12:00

12:30

Expiry

Break

Break

Break

D.2. The role of renal aponeurosis in the treatment of hypertension

Kyriakos Dimitriadis

Co-organization with the organization

EPILYO.png
bottom of page